These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
95 related items for PubMed ID: 8951155
1. Involvement of the rapid increase in cAMP content in the vanadate-stimulated release of lipoprotein lipase activity from rat fat pads. Motoyashiki T, Morita T, Ueki H. Biol Pharm Bull; 1996 Nov; 19(11):1412-6. PubMed ID: 8951155 [Abstract] [Full Text] [Related]
3. Sodium orthovanadate increases phospholipase A2 activity in isolated rat fat pads: a role of phospholipase A2 in the vanadate-stimulated release of lipoprotein lipase activity. Morita T, Imagawa T, Kanagawa A, Ueki H. Biol Pharm Bull; 1995 Feb; 18(2):347-9. PubMed ID: 7742810 [Abstract] [Full Text] [Related]
4. Inhibition of increasing effect of vanadate on glycogen content and lipoprotein lipase activity in fat pads by 5-N,N-hexamethylene amiloride. Ueki H, Sera M, Tominaga N, Morita T, Sugino E, Hibino S. Chem Pharm Bull (Tokyo); 1992 Feb; 40(2):542-3. PubMed ID: 1606655 [Abstract] [Full Text] [Related]
12. A vanadyl sulfate-bovine serum albumin complex stimulates the release of lipoprotein lipase activity from isolated rat fat pads through an increase in the cellular content of cAMP and myo-inositol 1,4,5-trisphosphate. Motoyashiki T, Miyake M, Yoshida A, Morita T, Ueki H. Biol Pharm Bull; 1999 Aug; 22(8):780-6. PubMed ID: 10480313 [Abstract] [Full Text] [Related]
13. Orthovanadate decreases the leptin content in isolated mouse fat pads via proteasome activation. Yoshida A, Hirano K, Motoyashiki T, Morita T, Ueki H. Arch Biochem Biophys; 2002 Oct 15; 406(2):253-60. PubMed ID: 12361713 [Abstract] [Full Text] [Related]
14. Orthovanadate stimulates cyclic guanosine monophosphate-inhibited cyclic adenosine monophosphate phosphodiesterase activity in isolated rat fat pads through activation of particulate myelin basic protein kinase by protein tyrosine kinase. Ueki H, Mitsugi S, Kawashima Y, Motoyashiki T, Morita T. Endocrinology; 1997 Jul 15; 138(7):2784-9. PubMed ID: 9202218 [Abstract] [Full Text] [Related]
15. Orthovanadate stimulates cAMP phosphodiesterase 3 activity in isolated rat hepatocytes through mitogen-activated protein kinase activation dependent on cAMP-dependent protein kinase. Watanabe T, Satoo H, Kohara K, Takami R, Motoyashiki T, Morita T, Ueki H. Biol Pharm Bull; 2004 Jun 15; 27(6):789-96. PubMed ID: 15187419 [Abstract] [Full Text] [Related]
16. Effect of orthovanadate on platelet aggregation induced by platelet-activating factor. Suenaga A, Ueki H. Biol Pharm Bull; 2004 Nov 15; 27(11):1859-63. PubMed ID: 15516737 [Abstract] [Full Text] [Related]
17. Release of lipoprotein lipase from Ehrlich ascites tumor produced by an association with a rapid increase in cyclic AMP content. Morita T, Ueki H, Kanagawa A. Cancer Lett; 1998 Jan 09; 122(1-2):37-42. PubMed ID: 9464489 [Abstract] [Full Text] [Related]
18. Isoproterenol increases active lipoprotein lipase in adipocyte medium and in rat plasma. Ballart X, Siches M, Peinado-Onsurbe J, López-Tejero D, Llobera M, Ramírez I, Robert MQ. Biochimie; 2003 Oct 09; 85(10):971-82. PubMed ID: 14644552 [Abstract] [Full Text] [Related]
19. Protein kinase inhibitor H-7 increases lipoprotein lipase activity in isolated rat fat pads. Morita T, Tsuruzono Y, Ueki H. Chem Pharm Bull (Tokyo); 1991 Sep 09; 39(9):2449-50. PubMed ID: 1804558 [Abstract] [Full Text] [Related]
20. Increase in lipoprotein lipase activity in isolated rat adipose tissue by selenate. Ueki H, Ohkura Y, Motoyashiki T, Tominaga N, Morita T. Biol Pharm Bull; 1993 Jan 09; 16(1):6-10. PubMed ID: 7690291 [Abstract] [Full Text] [Related] Page: [Next] [New Search]